Milestone Scientific (NYSE:MLSS) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a report published on Tuesday. The brokerage issued a hold rating on the stock.

Milestone Scientific Stock Performance

MLSS stock opened at $0.57 on Tuesday. Milestone Scientific has a one year low of $0.52 and a one year high of $1.35. The firm has a 50-day moving average of $0.66 and a two-hundred day moving average of $0.71. The firm has a market capitalization of $43.77 million, a PE ratio of -5.71 and a beta of 0.97.

Milestone Scientific (NYSE:MLSS) last issued its quarterly earnings results on Friday, March 29th. The company reported ($0.03) EPS for the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%. The firm had revenue of $2.26 million during the quarter.

Institutional Investors Weigh In On Milestone Scientific

Several hedge funds have recently bought and sold shares of the business. Northern Trust Corp increased its holdings in shares of Milestone Scientific by 10.8% in the 2nd quarter. Northern Trust Corp now owns 95,193 shares of the company’s stock valued at $83,000 after purchasing an additional 9,272 shares during the period. State Street Corp increased its stake in Milestone Scientific by 15.7% in the 2nd quarter. State Street Corp now owns 111,585 shares of the company’s stock valued at $102,000 after buying an additional 15,103 shares during the period. Royal Bank of Canada purchased a new stake in Milestone Scientific in the 1st quarter worth approximately $30,000. Jane Street Group LLC acquired a new stake in shares of Milestone Scientific during the 1st quarter valued at $35,000. Finally, AE Wealth Management LLC purchased a new position in shares of Milestone Scientific during the 3rd quarter valued at $26,000. 5.79% of the stock is owned by hedge funds and other institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical.